Five ampoules chart in Korea. Zero chart in the US.

Every week we compare the same store in the same week: Olive Young's Korean top 100 against its US-facing top 100. Most ingredients differ by degree. A few differ absolutely — and the most interesting one this week is not an ingredient at all. It is a format.

Ampoule appears in five Korean top-100 product names and zero US-facing ones. Not fewer. None.

A word that does not survive the border

An ampoule, in Korean skincare vocabulary, signals a concentrated treatment step — thinner than a cream, more potent than a toner, sold in a small bottle and understood instantly by Korean shoppers as a serious step.

US product naming has no equivalent slot. The same formula crossing over tends to get renamed "serum" or "treatment," because that is the word an American shopper can price and place in a routine. What we are seeing on the chart is likely not the product failing to cross — it is the word failing to cross.

Barrier shows the same shape: four Korean products, zero US. Korea sells barrier care as its own category; the US market largely folds it into "hydrating" or "soothing."

The gap that runs the other way

One ingredient reverses. Probiotics: one product in Korea, five in the US. It is the only entry on our board where the US-facing chart leads Korea, and it is a useful corrective — the border is not a one-way valve where Korea is always ahead. Some categories are simply more American.

Hyaluronic acid is the widest one-directional gap: nine Korean products to one US-facing. Mature demand in one market, near-absence in the other, for an ingredient neither market considers exotic.

What we'll watch next

The testable version of the naming hypothesis: if ampoule is a language problem rather than a demand problem, US-facing charts should show the same formulas under "serum" while ampoule stays at zero. As the archive deepens we can track whether the ampoule count ever leaves zero — and if it does, which channel blinks first.